Aerocrine Signs Distribution Agreement With Third Largest Chinese Pharmaceutical Company

Published: Sep 25, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B) today announces the signing of an import and distribution agreement with Shanghai Pharmaceuticals Holding Co., Ltd. (SPH) for Aerocrine’s products for the Chinese market. SPH is the third largest pharmaceutical company in China, with an extensive network of local sales people across China.

Back to news